The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, WuXi Biologics (Cayman)'s share price is $3.36.
WuXi Biologics (Cayman)'s Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.10. Hence, WuXi Biologics (Cayman)'s PS Ratio for today is 3.07.
Good Sign:
WuXi Biologics (Cayman) Inc stock PS Ratio (=3.43) is close to 10-year low of 3.24
The historical rank and industry rank for WuXi Biologics (Cayman)'s PS Ratio or its related term are showing as below:
WXXWY'
s PS Ratio Range Over the Past 10 Years
Min: 3.12 Med: 35.62 Max: 90.01
Current: 3.15
During the past 10 years, WuXi Biologics (Cayman)'s highest PS Ratio was 90.01. The lowest was 3.12. And the median was 35.62.
WXXWY's PS Ratio is ranked better than 75.91% of 992
companies
in the Biotechnology industry
Industry Median: 8.85
vs WXXWY: 3.15
During the past 10 years, WuXi Biologics (Cayman)'s highest 3-Year average Revenue per Share Growth Rate was 65.30% per year. The lowest was 42.10% per year. And the median was 53.35% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WuXi Biologics (Cayman)'s PS Ratio
For the Biotechnology subindustry, WuXi Biologics (Cayman)'s PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi Biologics (Cayman)'s PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s PS Ratio distribution charts can be found below:
* The bar in red indicates where WuXi Biologics (Cayman)'s PS Ratio falls into.
WuXi Biologics (Cayman) PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
WuXi Biologics (Cayman)'s Share Price of today is $3.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi Biologics (Cayman)'s Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $1.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
WuXi Biologics (Cayman) (OTCPK:WXXWY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
WuXi Biologics (Cayman) PS Ratio Related Terms
Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
WuXi Biologics (Cayman) (WuXi Biologics (Cayman)) Business Description
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WXXWY has been successfully added to your 